Muller, W. Et Al. 2023. Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants. NEW ENGLAND JOURNAL OF MEDICINE , vol.388 , 1533-1534.

Muller, W., Mathi, S. A., Nunez, B., Study Group, N., & Günlemez, A., (2023). Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants. NEW ENGLAND JOURNAL OF MEDICINE , vol.388, 1533-1534.

Muller, William Et Al. "Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants," NEW ENGLAND JOURNAL OF MEDICINE , vol.388, 1533-1534, 2023

Muller, William Et Al. "Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants." NEW ENGLAND JOURNAL OF MEDICINE , vol.388, pp.1533-1534, 2023

Muller, W. Et Al. (2023) . "Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants." NEW ENGLAND JOURNAL OF MEDICINE , vol.388, pp.1533-1534.

@article{article, author={William Muller Et Al. }, title={Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2023, pages={1533-1534} }